Brigham and Women's Hospital

Medistem collaborates with Boston academic researcher

Wednesday, July 31, 2013 11:45 AM

Medistem, developer of Endometrial Regenerative Cell (ERC), a universal donor adult stem cell product, will collaborate with Reza Abdi, M.D., transplant nephrologist at Brigham and Women's Hospital and assistant professor of medicine, Harvard Medical School. The company will provide Abdi with its ERCs and it is expected that his research would support FDA clearance to initiate clinical trials to use ERCs as a treatment for type 1 diabetes. The company has FDA clearance to initiate a dose-escalating phase I clinical trial to use ERCs in patients with critical limb ischemia, a complication of diabetes.

More... »

Boston-based Alzheimer's disease research highlighted at Alzheimer's Association International Conference 2013

Tuesday, July 16, 2013 09:35 AM

Three studies reported at the Alzheimer's Association International Conference 2013 (AAIC) demonstrate the vitality and diversity of Alzheimer's disease research being conducted in Boston, the host city for this year's conference.

More... »

Whole genome sequencing of Alzheimer’s patients to be made available to researchers

Friday, July 12, 2013 01:28 PM

The Alzheimer's Association and the Brin Wojcicki Foundation have announced new data has been generated by the "Big Data" project for Alzheimer's disease. The data will be made freely available to researchers worldwide to advance Alzheimer's science.

More... »

Third Rock launches MyoKardia with $38M for genetic heart disease

Friday, September 21, 2012 10:51 AM

Third Rock Ventures, a venture capital firm of Boston, Mass., has formed new company MyoKardia with a $38 million Series A financing. MyoKardia is developing a pipeline of novel small molecule therapeutics that address key clinical needs for patients with genetic heart disease.

More... »

Sanofi in research collaboration with BWH for type 1 diabetes

Thursday, July 19, 2012 02:23 PM

Sanofi has announced a new research collaboration with Boston’s Brigham and Women's Hospital (BWH), a teaching and research affiliate of Harvard Medical School, focused on immunology of type 1 diabetes. The two organizations will share knowledge and apply their respective expertise in basic and applied research regarding diabetes and drug target and candidate development.

More... »